Publications by authors named "J M Wilschut"

Purpose: Human papillomavirus (HPV) infection is the major cause of (pre)malignant cervical lesions. We previously demonstrated that Vvax001, a replication-incompetent Semliki Forest virus (SFV) vaccine encoding HPV type 16 (HPV16) E6 and E7, induced potent anti-E6 and -E7 cytotoxic T-cell responses. Here, we investigated the clinical efficacy of Vvax001 in patients with HPV16-positive cervical intraepithelial neoplasia grade 3 (CIN3).

View Article and Find Full Text PDF

Background: Intravascular ultrasound (IVUS)-guided optimization of suboptimal fractional flow reserve (FFR) following percutaneous coronary intervention (PCI) results in a significant increase in both post-PCI FFR and minimal lumen and stent areas (MLA and MSA, respectively). However, the impact of clinical presentation with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) versus chronic coronary syndrome (CCS) on the efficacy of PCI optimization remains unknown.

Methods: This was a prespecified subgroup analysis of the FFR REACT trial comparing IVUS-guided PCI optimization versus no further treatment in 291 patients with a post-PCI FFR < 0.

View Article and Find Full Text PDF

Atherosclerosis is the predominant underlying etiopathology of coronary artery disease. Changes in plaque phenotype from stable to high risk may spur future major adverse cardiac events (MACE). Different pharmacological therapies have been implemented to mitigate this risk.

View Article and Find Full Text PDF
Article Synopsis
  • This study investigates whether crushed prasugrel loading doses administered before hospital arrival can benefit patients with large myocardial infarctions and ST-segment elevation myocardial infarction (STEMI).
  • It includes data from the CompareCrush trial, focusing on 532 patients, of which 331 had a large myocardial area confirmed by prehospital ECG.
  • Results show that crushed prasugrel significantly improved postprocedural blood flow in STEMI patients with a large area at risk, suggesting it could be a safe and effective strategy for enhancing myocardial reperfusion in this high-risk group.
View Article and Find Full Text PDF

Introduction: Invasive meningococcal disease (IMD) caused by Neisseria meningitidis is a rapidly progressing, rare disease that often presents as meningitis or sepsis. It mostly affects infants and adolescents, with high fatality rates or long-term sequelae. In the Netherlands, serogroup B (MenB) is most prevalent.

View Article and Find Full Text PDF